Cormorant Asset Management, LP
SEC Form 4 insider trading activity
Cormorant Asset Management, LP has filed 4 SEC Form 4 filings (4 transaction rows) across 3 companies, including CRBP, DRUG, EYPT, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Nov 2, 2026.
On the most recent filing, Cormorant Asset Management, LP is listed as Insider at Corbus Pharmaceuticals Holdings, Inc. Inside the rolling window, Cormorant Asset Management, LP reported no open-market purchases and 4 open-market sales totaling $12.8M in CRBP and DRUG and EYPT. The largest disclosed transaction in the window is a sale of 109,331 DRUG shares on Apr 28, 2026, worth $9.8M.
Companies traded
Other insiders at CRBP
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$12.8M
reported sales (SEC code S)
Companies
3
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Cormorant Asset Management, LP made?
Cormorant Asset Management, LP has filed 4 SEC Form 4 filings (4 transaction rows) across 3 companies, including CRBP, DRUG, EYPT since 2025.
Which companies does Cormorant Asset Management, LP trade?
Cormorant Asset Management, LP has filed SEC Form 4 disclosures for 3 companies, including CRBP, DRUG, EYPT.
When was Cormorant Asset Management, LP's most recent SEC Form 4 filing?
Cormorant Asset Management, LP's most recent SEC Form 4 filing on Tracefour is dated Nov 2, 2026.
What is Cormorant Asset Management, LP's total buy and sell value in the current window?
Inside the rolling retention window, Cormorant Asset Management, LP bought $0 and sold $12.8M based on SEC Form 4 filings.
What was Cormorant Asset Management, LP's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 109,331 DRUG shares on 2026-04-28, worth $9.8M, per SEC Form 4 filings.